Biotech

All Articles

ReNeuron leaving objective substitution after missing fundraising goal

.ReNeuron has signed up with the long listing of biotechs to leave behind London's AIM stock exchang...

MBX apply for IPO to take opposition to Ascendis into phase 3

.MBX Biosciences has included in the recent spurt of IPO filings. The biotech, which submitted its d...

FDA increases probe right into Lykos' MDMA trials: WSJ

.For Lykos Therapies as well as the provider's potential MDMA-assisted therapy for trauma (POST-TRAU...

Gene editor Tome laying off 131 employees

.Simply days after gene publisher Volume Biosciences introduced secret functional slices, a clearer ...

Repare lays off 25% of workers as biotech halts preclinical R&ampD

.Repare Rehab is giving up a quarter of its staff as the oncology biotech scales back its own precli...

J &amp J declare FDA permission of $6.5 B autoimmune drug

.Johnson &amp Johnson has taken an additional step toward realizing a profit on its $6.5 billion nip...

Gain's phase 1 gain leads technique to confirm Parkinson's medication's worth

.Increase Therapies has actually established its direct showing the efficiency of its own Parkinson'...

Actinogen records new stage 2 data to restore anxiety medication

.Actinogen Medical's hopes-- and supply rate-- have actually rebounded somewhat coming from earlier ...

Pfizer and Main include Quotient to multibillion-dollar formula

.Main Pioneering and also Pfizer have incorporated Quotient in to their 10-program collaboration, in...

Bayer markers $547M treaty to press boundaries of noncoding RNA

.Bayer executives were interested to tension to Tough this summer months that the German pharma tita...